| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,065 |
3,556 |
$264K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,192 |
1,055 |
$104K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
421 |
406 |
$42K |
| 99384 |
|
81 |
76 |
$13K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
335 |
282 |
$11K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
183 |
177 |
$9K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
68 |
61 |
$5K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
249 |
236 |
$5K |
| 99383 |
|
23 |
21 |
$3K |
| 90686 |
|
156 |
153 |
$2K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
75 |
72 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
89 |
87 |
$1K |
| 87428 |
|
20 |
20 |
$1K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
13 |
13 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
57 |
57 |
$764.62 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
89 |
87 |
$673.34 |
| 90658 |
|
60 |
56 |
$521.89 |
| 81000 |
|
22 |
19 |
$43.19 |
| 81002 |
|
13 |
12 |
$31.78 |